Articles published by ImmunityBio, Inc.
![](https://mms.businesswire.com/media/20240812222947/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240806552447/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240620264106/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240607246847/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240516520260/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240507050323/en/2122218/22/I05.07.2024_-_mmunityBio-Dunkirk-New-York-GMP-Manufacturing-Facility%5B1%5D.jpg)
ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®
May 07, 2024
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20240502530543/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240430306875/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240424428572/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240422820209/en/2106251/5/Carton-%26-Vial.jpg)
![](https://mms.businesswire.com/media/20240205300717/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20240102781220/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20231116785447/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20231107571659/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20231026155505/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20231023256922/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230911111993/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
ImmunityBio Announces $470 Million Equity and Debt Financing From Founder, Dr. Patrick Soon-Shiong and Nant Entities
September 11, 2023
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20230803203044/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
ImmunityBio Names Enrique Diloné as Chief Technology Officer
August 03, 2023
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20230720250779/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
July 20, 2023
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20230710232438/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230522005312/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230425005133/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230424006033/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230216005392/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20230215005529/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
ImmunityBio Announces Execution of $50 Million Equity Financing with Multiple Institutional Investors
February 15, 2023
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20230119005337/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20221212005296/en/1463552/22/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20221117005393/en/1463552/5/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20221027005269/en/1463552/5/BusinessWire_-ImmunityBio.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.